Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Nikiforuk, Agnieszka ^a   Kos, Tomasz ^a   Fijał, Katarzyna ^a   Hołuj, Małgorzata ^a   Rafa, Dominik ^a   Popik, Piotr ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; AMISULPRIDE; CLOZAPINE; KETAMINE; SEROTONIN 7 RECEPTOR;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SELECTIVITY; MALE; NEGATIVE SYNDROME; NONHUMAN; PATTERN RECOGNITION; POSITIVE SYNDROME; PREPULSE INHIBITION; RAT; SCHIZOPHRENIA; SELECTIVE ATTENTION; SOCIAL INTERACTION; STARTLE REFLEX; TASK PERFORMANCE;

ANIMALS; KETAMINE; MALE; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; SULFONAMIDES; SULPIRIDE;

RATTUS;

EID: 84878864178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066695     Document Type: Article

References (47)

1. Hedlund PB, (2009) The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology 206: 345-354.
2. Leopoldo M, Lacivita E, Berardi F, Perrone R, Hedlund PB, (2011) Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther 129: 120-148.
3. Matthys A, Haegeman G, Van CK, Vanhoenacker P, (2011) Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol Neurobiol 43: 228-253.
4. Cifariello A, Pompili A, Gasbarri A, (2008) 5-HT(7) receptors in the modulation of cognitive processes. Behav Brain Res 195: 171-179.
5. Roberts AJ, Hedlund PB, (2012) The 5-HT(7) receptor in learning and memory. Hippocampus 22: 762-771.
6. Bonaventure P, Aluisio L, Shoblock J, Boggs JD, Fraser IC, et al. (2011) Pharmacological blockade of serotonin 5-HT(7) receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission. PLoS One 6: e20210.
7. Horiguchi M, Huang M, Meltzer HY, (2011) The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. J Pharmacol Exp Ther 338: 605-614.
8. Horisawa T, Ishibashi T, Nishikawa H, Enomoto T, Toma S, et al. (2011) The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone. Behav Brain Res 220: 83-90.
9. McLean SL, Woolley ML, Thomas D, Neill JC, (2009) Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. Psychopharmacology (Berl) 206: 403-414.
10. Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, et al. (2009) Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl) 205: 119-128.
11. Ishibashi T, Horisawa T, Tokuda K, Ishiyama T, Ogasa M, et al. (2010) Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. J Pharmacol Exp Ther 334: 171-181.
12. Elvevag B, Goldberg TE, (2000) Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14: 1-21.
13. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, et al. (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 72: 29-39.
14. Gilmour G, Arguello A, Bari A, Brown VJ, Carter C et al. (2012) Measuring the construct of executive control in schizophrenia: Defining and validating translational animal paradigms for discovery research. Neurosci Biobehav Rev. 10.1016/j.neubiorev.2012.04.006.
15. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA, (2009) Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122: 150-202.
16. Birrell JM, Brown VJ, (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20: 4320-4324.
17. Ennaceur A, Delacour J, (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31: 47-59.
18. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, et al. (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20: 106-118.
19. Neill JC, Barnes S, Cook S, Grayson B, Idris NF, et al. (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128: 419-432.
20. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, et al. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
21. Hagan JJ, Price GW, Jeffrey P, Deeks NJ, Stean T, et al. (2000) Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol 130: 539-548.
22. Pouzet B, Didriksen M, Arnt J, (2002) Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol Biochem Behav 71: 655-665.
23. Lopuch S, Popik P, (2011) Cooperative behavior of laboratory rats in an instrumental task. J Comp Psychol 125: 250-253.
24. Willey AR, Varlinskaya EI, Spear LP, (2009) Social interactions and 50 kHz ultrasonic vocalizations in adolescent and adult rats. Behav Brain Res 202: 122-129.
25. Nikiforuk A, Golembiowska K, Popik P, (2010) Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. Eur Neuropsychopharmacol 20: 37-48.
26. Gastambide F, Mitchell SN, Robbins TW, Tricklebank MD, Gilmour G (2013) Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat. Eur Neuropsychopharmacol 10.1016/j.euroneuro.2013.03.002 [doi].
27. Bakshi VP, Swerdlow NR, Geyer MA, (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271: 787-794.
28. Meneses A, (2004) Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behav Brain Res 155: 275-282.
29. Liy-Salmeron G, Meneses A, (2008) Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model. Hippocampus 18: 965-974.
30. Roberts AJ, Krucker T, Levy CL, Slanina KA, Sutcliffe JG, et al. (2004) Mice lacking 5-HT receptors show specific impairments in contextual learning. Eur J Neurosci 19: 1913-1922.
31. Sarkisyan G, Hedlund PB, (2009) The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav Brain Res 202: 26-31.
32. Waters KA, Stean TO, Hammond B, Virley DJ, Upton N, et al. (2012) Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition. Behav Brain Res 228: 211-218.
33. Nikiforuk A, (2012) Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Behav Brain Res 226: 118-123.
34. Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, et al. (2002) SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties. Bioorg Med Chem Lett 12: 3341-3344.
35. Wesolowska A, Kowalska M, (2008) Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep 60: 464-474.
36. Moghaddam B, Adams BW, (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352.
37. Watson DJ, Marsden CA, Millan MJ, Fone KC, (2012) Blockade of dopamine D(3) but not D(2) receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment. Int J Neuropsychopharmacol 15: 471-484.
38. Galici R, Boggs JD, Miller KL, Bonaventure P, Atack JR, (2008) Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. Behav Pharmacol 19: 153-159.
39. Semenova S, Geyer MA, Sutcliffe JG, Markou A, Hedlund PB, (2008) Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biol Psychiatry 63: 98-105.
40. Varty GB, Bakshi VP, Geyer MA, (1999) M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20: 311-321.
41. Mahe C, Loetscher E, Feuerbach D, Muller W, Seiler MP, et al. (2004) Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Eur J Pharmacol 495: 97-102.
42. Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E, (2006) Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51: 578-586.
43. Bruins Slot LA, Kleven MS, Newman-Tancredi A, (2005) Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat. Neuropharmacology 49: 996-1006.
44. Snigdha S, Neill JC, (2008) Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors. Behav Brain Res 191: 26-31.
45. Panksepp J, (2005) Psychology. Beyond a joke: from animal laughter to human joy? Science 308: 62-63.
46. Panksepp J, Burgdorf J, (2000) 50-kHz chirping (laughter?) in response to conditioned and unconditioned tickle-induced reward in rats: effects of social housing and genetic variables. Behav Brain Res 115: 25-38.
47. Wright JM, Dobosiewicz MR, Clarke PB, (2013) The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations. Psychopharmacology (Berl) 225: 853-868.